JAZZ is a temporary implant to be used in orthopedic surgery. The JAZZ System is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures.

The indications for use include the following applications:

Spinal trauma surgery, used in sublaminar or facet wiring techniques;
Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinal deformities such as adolescent idiopathic scoliosis, adult scoliosis, kyphosis and spondylolisthesis;
Spinal degenerative surgery, as an adjunct to spinal fusions.

The JAZZ System may also be used in conjunction with other medical implants made of titanium alloy or cobalt-chromium-molybdenum alloy whenever "wiring" may help secure the attachment of other implants.

Device Description

The JAZZ Systems consists of the following components: JAZZ Connector, JAZZ Claw Connector, JAZZ Claw hooks, JAZZ Lock Connector, various rods, and JAZZ Braid (a.k.a. Band) with buckle. The JAZZ Band is inserted into various JAZZ connectors and is used to attach them to the spine.

AI/ML Overview

The provided document is a 510(k) summary for a medical device (JAZZ System, including JAZZ Band) and does not contain the level of detail required to answer all parts of your request regarding acceptance criteria and a detailed study proving device performance in the context of an Artificial Intelligence (AI) or machine learning device. This document describes a traditional medical device (a temporary implant for orthopedic surgery) and its regulatory clearance process, not an AI/ML powered medical device.

Therefore, for aspects related to AI/ML device evaluation (like sample sizes for test sets, data provenance, expert ground truth establishment, MRMC studies, standalone performance of an algorithm, and training set details), the information is not applicable as the JAZZ System is a physical implant, not a software-based diagnostic or predictive tool.

However, I can extract the relevant information regarding the performance data provided for this specific device:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria	Reported Device Performance
Biocompatibility	Equivalent to predicate (assessed per ISO 10993)
Mechanical Performance	Equivalent to predicate (assessed via static tensile testing)

2. Sample size used for the test set and the data provenance
Not applicable. This is a physical implant, and the performance assessment described is based on testing the physical properties of the device, not a classification or prediction task on a "test set" of data in the AI/ML sense. Data for biocompatibility and mechanical testing would involve a certain number of test samples of the device and testing materials, but these are not disclosed in this summary.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. Ground truth as typically understood for AI/ML devices is not relevant here. Biocompatibility and mechanical performance are assessed through laboratory testing against established standards and engineering principles.

4. Adjudication method for the test set
Not applicable.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is not an AI/ML device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an AI/ML device.

7. The type of ground truth used
For biocompatibility, the ground truth would be adherence to the ISO 10993 standard. For mechanical performance, the ground truth would be demonstrating equivalent or superior strength and integrity compared to the previously cleared predicate device, based on established engineering specifications and static tensile testing protocols.

8. The sample size for the training set
Not applicable. This is not an AI/ML device.

9. How the ground truth for the training set was established
Not applicable. This is not an AI/ML device.

Additional Information from the Document:

Device Name: JAZZ System, including JAZZ Band
Purpose of 510(k): To modify the JAZZ Band component. Minor changes were made to the ultrasonic welding of the braid and the design of the metal buckle.
Predicate Devices: Implanet's JAZZ System (K151740), Implanet's JAZZ Systems (K162764), Implanet's JAZZ Lock (K153348).
Conclusion: The modified JAZZ Band is as safe and effective as the predicate JAZZ Braid. The JAZZ Band has the same intended uses and indications, and similar technological characteristics and principles of operation as its predicate device. Performance data (biocompatibility and mechanical performance) demonstrate that the modified JAZZ Band is substantially equivalent.

Summary

{0}------------------------------------------------

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 9, 2017

Implanet, S.A. % Janice Hogan Regulatory Counsel Hogan Lovells US LLP 1835 Market St., 29th Floor Philadelphia, Pennsylvania 19103

Re: K170730

Trade/Device Name: JAZZ System, including JAZZ Band Regulation Number: 21 CFR 888.3010 Regulation Name: Bone Fixation Cerclage Regulatory Class: Class II Product Code: OWI Dated: April 3, 2017 Received: April 3, 2017

Dear Janice Hogan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement on last page

510(k) Number (if known) K170730

Device Name JAZZ System, including JAZZ Band

Indications for Use (Describe)

The indications for use include the following applications:

Spinal trauma surgery, used in sublaminar or facet wiring techniques; 1.
Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinaldeformities such as adolescent 2. idiopathic scoliosis, adult scoliosis, kyphosis and spondylolisthesis;
ന് Spinal degenerative surgery, as an adjunct to spinal fusions.

The JAZZ System may also be used in conjunction with other medical implants made of titanium alloy or cobalt-chromium-molybenum alloy whenever "wiring" may help secure the attachment of other implants.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

PSC Publishing Services (301) 443-6740 EF

{3}------------------------------------------------

510(k) SUMMARY Implanet's JAZZ System. including JAZZ Band K170730

Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared:

Implanet S.A. Technopole Bordeaux Montesquieu Allée Francois Magendie 33650 Martillac France

Phone: +33 557 995 555 Facsimile: +33 557 995 700

Contact Person: Regis Le Couedic, Director of Quality and Regulatory Affairs; Chief Technology Officer

Date Prepared: June 8, 2017

Application Correspondent:

Janice M. Hogan 1835 Market Street, 29th Floor Philadelphia, PA 19103 Phone: (267) 675-4611

Name of Device:

JAZZ System, including JAZZ Band

Common or Usual Name:

Bone, Fixation, Cerclage, Sublaminar

Classification Name:

Bone, Fixation, Cerclage

Primary Product Code

OWI

Regulation Number

21 CFR § 888.3010

Device Class

Class II

{4}------------------------------------------------

Predicate Devices

Implanet's JAZZ System (K151740) (primary)

Implanet's JAZZ Systems (K162764) (additional)

Implanet's JAZZ Lock (K153348) (additional)

Device Description

Intended Use/Indications for Use

The indications for use include the following applications:

1. Spinal trauma surgery, used in sublaminar or facet wiring techniques;
1. Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinaldeformities such as adolescent idiopathic scoliosis, adult scoliosis, kyphosis and spondylolisthesis:
1. Spinal degenerative surgery, as an adjunct to spinal fusions.

The JAZZ System may also be used in coniunction with other medical implants made of titanium alloy or cobalt-chromium-molybdenum alloy whenever "wiring" may help secure the attachment of other implants.

Purpose of 510(k)

The purpose of this 510(k) is to modify the Jazz Band component of the JAZZ Systems. Minor changes are being made to the ultrasonic welding of the braid and the design of the metal buckle used to tighten the braid.

Performance Data

These changes were assessed per ISO 10993 and static tensile testing to show equivalent biocompatibility and mechanical performance to the predicate.

Conclusions

The modified JAZZ Band is as safe and effective as the predicate JAZZ Braid. The JAZZ Band has the same intended uses and indications, as well as similar technological characteristics and principles of operation as its predicate device. In addition, the minor technological differences between the JAZZ Band and its predicate devices raise no new issues of safety or effectiveness. Performance data demonstrate that the modified JAZZ

{5}------------------------------------------------

Band is as safe and effective as the predicate JAZZ Braid. Thus, the JAZZ Band is substantially equivalent.

Regulation Number and Section

§ 888.3010 Bone fixation cerclage.

(a)
Identification. A bone fixation cerclage is a device intended to be implanted that is made of alloys, such as cobalt-chromium-molybdenum, and that consists of a metallic ribbon or flat sheet or a wire. The device is wrapped around the shaft of a long bone, anchored to the bone with wire or screws, and used in the fixation of fractures.(b)
Classification. Class II.